Richard Fagan and Amit Nathwani

A gene therapy for haemophilia – from the lab to the patient

30 November 2022 | UCLB News

At our Winter Showcase event on 16 November 2022, we highlighted some of our recent successes in translating research conducted at UCL into technologies and innovations that have a real and positive impact on individuals and society as a whole.

Dr Richard Fagan (UCLB’s Director of BioPharm) and Professor Amit Nathwani, Professor of Immunology at UCL, gave a fascinating insight into how Professor Nathwani’s research is being translated into treatments for patients.

Read the full article from Bristows.